Creative Planning’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Creative Planning’s Portfolio AST.WS Stock Details AST.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-126	Closed	–	–	4718
2017 Q2	$0	Sell	126 -5	-4%	-$2	﹤0.01%	5115
2017 Q1	$0	Buy	131 +3	+2%	+$1	﹤0.01%	5176
2016 Q4	$0	Buy	128 +20	+19%	+$11	﹤0.01%	5129
2016 Q3	$0	Sell	108 -4	-4%	-$1	﹤0.01%	4970
2016 Q2	$0	Buy	+112	New	+$58	﹤0.01%	4780

Creative Planning's AST.WS Position: Q3 2017 in Review

Creative Planning sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 126 shares.

Creative Planning first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

Creative Planning reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 126 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
Creative Planning first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
Creative Planning's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.